Tailored Support for Type 2 Diabetes Patients With an Acute Coronary Event After Discharge From Hospital (Diacourse)

July 25, 2014 updated by: Prof. G.E.H.M. Rutten, UMC Utrecht

Background: In type 2 diabetes mellitus patients, an acute coronary event (ACE) may result in a decreased quality of life and increased distress. According to the American Diabetes Association, transition from the acute care setting is a high-risk time for all patients, but tailored support specific to diabetes is scarce in that period. The investigators developed an intervention by a diabetes nurse to help diabetic patients reduce distress after their first ACE. The intervention is based on Bandura's Social Cognitive Theory, Leventhal's Common Sense Model, and on results of focus groups which were conducted to define the needs and wishes of type 2 diabetes patients and their partners regarding professional support after an ACE. The aim of this study is to evaluate the effectiveness of the intervention to reduce distress. The hypothesis is that patients who receive the intervention will have less diabetes related distress compared to the control group.

Methods/Design: Randomized controlled trial. Patients will be recruited directly after discharge from hospital. A diabetes nurse will visit the patients in the intervention group (n = 100) within three weeks after discharge from hospital, two weeks later and two months later. The control group (n = 100) will receive a telephone consultation. The primary outcome is diabetes related distress, measured with the Problem Areas in Diabetes questionnaire (PAID). Secondary outcomes are quality of life, anxiety, depression, HbA1c, blood pressure and lipids. Mediating variables are self-management, self-efficacy and illness representations. Variables will be measured with questionnaires directly after discharge from hospital and five months later. Biomedical variables will be obtained from the records from the primary care physician and the hospital. Differences between groups in change over time will be analyzed according to the intention-to-treat principle.

Discussion: Type 2 diabetes patients who experience a first ACE need tailored support after discharge from the hospital. This trial will provide evidence of the effectiveness of a supportive intervention to reduce distress in these patients.

Study Overview

Detailed Description

See citation design paper

Study Type

Interventional

Enrollment (Actual)

201

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Amersfoort, Netherlands
        • Meander Medical Center
      • Apeldoorn, Netherlands
        • Gelre Hospitals
      • Bergen op Zoom, Netherlands
        • Lievensberg Hospital
      • Breda, Netherlands
        • Amphia Hospital
      • Den Helder, Netherlands
        • Gemini Hospital
      • Goes, Netherlands
        • Admiraal de Ruyter Hospital
      • Gorinchem, Netherlands
        • Beatrix Hospital
      • Hoorn, Netherlands
        • Westfriesgasthuis
      • Nieuwegein, Netherlands
        • Sint Antonius Hospital
      • Nijmegen, Netherlands
        • Canisius Wilhelmina Hospital
      • Utrecht, Netherlands
        • Diakonessenhuis
      • Utrecht, Netherlands
        • University Medical Center
      • Utrecht, Netherlands
        • Sint Antonius Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • History of type 2 diabetes (>1 year)
  • Discharged from the hospital after a first acute coronary event defined as a Myocardial Infarction (MI), Coronary Artery Bypass Graft (CABG) procedure or Percutaneous Transluminal Coronary Angioplasty (PTCA)
  • Sufficient knowledge of the Dutch language

Exclusion Criteria:

  • A serious illness or condition which will prevent full participation
  • Not able to fill in questionnaires

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Home visits
In addition to usual care the patients will receive three home visits from a trained diabetes nurse. The first visit (65 minutes) is within three weeks after discharge from the hospital; the second visit (45 minutes) is two weeks later and the third visit (45 minutes) is two months after the second home visit.
In addition to usual care the patients will receive three home visits from a trained diabetes nurse. The first visit (65 minutes) is within three weeks after discharge from the hospital; the second visit (45 minutes) is two weeks later and the third visit (45 minutes) is two months after the second home visit.
Other: Consultation by telephone
In addition to usual care patients will receive a consultation by telephone within three weeks after discharge to offer them personal attention. In this consultation they will get the opportunity to discuss in ten to fifteen minutes how they feel in the period after discharge.
In addition to usual care patients will receive a consultation by telephone within three weeks after discharge to offer them personal attention. In this consultation they will get the opportunity to discuss in ten to fifteen minutes how they feel in the period after discharge.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Diabetes related distress
Time Frame: At 2 weeks and 5 months after discharge from hospital
Diabetes related distress measure with the Problem Areas in Diabetes (PAID) questionnaire. The PAID is a Self-reported questionnaire consisting of twenty statements identified as common negative emotions related to living with diabetes. Each item is rated on a 5-point Likert scale, ranging from 0 ("not a problem") to 4 ("a serious problem"). The total score is transformed to a 0-100 scale, with higher score representing higher distress.
At 2 weeks and 5 months after discharge from hospital

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Well-being
Time Frame: At 2 weeks and 5 months after discharge from hospital
Measured with the WHO-Five Well-being Index (WHO-5). The five items covering positive mood (good spirits, relaxation), vitality (being active and waking up fresh and rested), and general interests (being interested in things) in the past two weeks
At 2 weeks and 5 months after discharge from hospital
Change in Quality of life
Time Frame: At 2 weeks and 5 months after discharge from hospital

Euroqol 5 Dimensions (EQ-5D) and the Euroqol Visual Scale (EQ-VAS). The EQ-5D measures general health status on five dimensions:

  1. Mobility
  2. Self-care
  3. Usual activities
  4. Pain/discomfort
  5. Anxiety/depression The EQ-VAS measures the overall health state on a graded, vertical line.
At 2 weeks and 5 months after discharge from hospital
Change in Anxiety and depression
Time Frame: At 2 weeks and 5 months after discharge from hospital
Measured with the Hospital Anxiety and Depression Scale (HADS). A questionnaire measuring anxiety (7 items) and depression (7 items).
At 2 weeks and 5 months after discharge from hospital
Change in Physical activity
Time Frame: At 2 weeks and 5 months after discharge from hospital
Measured with the International Physical Activity Questionnaire (IPAQ). 29 Items measure how many days' physical activities are performed during the past seven days in four domains (work, transportation, housework and leisure-time).
At 2 weeks and 5 months after discharge from hospital
Change in Self care
Time Frame: At 2 weeks and 5 months after discharge from hospital
Measured with the Summary of the Diabetes Self-Care Activities Measure (SDSCA). Eleven items assessing several aspects of the diabetes regimen: general diet, specific diet, exercise, blood glucose testing, foot care, and smoking. Items measure how many days a patient has performed self-care activities in the last seven days.
At 2 weeks and 5 months after discharge from hospital
Change in Diabetes coping
Time Frame: At 2 weeks and 5 months after discharge from hospital
Measured with the Diabetes Coping Measure (DCM) consisting of four scales measuring diabetes coping: tackling spirit, avoidance, passive resignation and diabetes integration.
At 2 weeks and 5 months after discharge from hospital
Change in Biomedical variables
Time Frame: At 2 weeks and 5 months after discharge from hospital
Blood pressure, blood lipids (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides) and body mass index
At 2 weeks and 5 months after discharge from hospital

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Self-efficacy
Time Frame: At 2 weeks and 5 months after discharge from hospital
Measured with the Confidence in Diabetes Self-care questionnaire consisting of 20 items measuring diabetes specific self-efficacy.
At 2 weeks and 5 months after discharge from hospital
Change in Illness perceptions
Time Frame: At 2 weeks and 5 months after discharge from hospital
Measured with the Illness Perception Questionnaire (IPQ) - short version. Questionnaire assessing the cognitive representation of illness, focuses on seven scales, assessing (1) Timeline acute/chronic and (2) Timeline cyclical (3) Consequences (4) Personal control (5) Treatment control (6) Illness coherence (7) Emotional representation
At 2 weeks and 5 months after discharge from hospital
Change in Spousal support
Time Frame: At 2 weeks and 5 months after discharge from hospital
Measured with the Active Engagement, Protective Buffering and Overprotection (ABO) questionnaire. Five items measure active engagement, eight items measure protective buffering and six items measure overprotection
At 2 weeks and 5 months after discharge from hospital

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Principal Investigator: Guy E. Rutten, Professor, UMC Utrecht

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2011

Primary Completion (Actual)

December 1, 2013

Study Completion (Actual)

December 1, 2013

Study Registration Dates

First Submitted

February 14, 2013

First Submitted That Met QC Criteria

February 26, 2013

First Posted (Estimate)

March 1, 2013

Study Record Updates

Last Update Posted (Estimate)

July 28, 2014

Last Update Submitted That Met QC Criteria

July 25, 2014

Last Verified

July 1, 2014

More Information

Terms related to this study

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type 2 Diabetes

Clinical Trials on Home visits

3
Subscribe